Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category

ATLANTA, Jan. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral contraceptive Balcoltra... Biopharmaceuticals, FDA Avion Pharmaceuticals, Balcoltra, levonorgestrel, ethinyl estradiol
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news